Tg Therapeutics (TGTX) EBT (2011 - 2026)
Tg Therapeutics (TGTX) posted quarterly EBT of $20.4 million for Q1 2026, up 272.4% year-over-year from $5.5 million in Q1 2025, and down 55.19% quarter-over-quarter from $45.4 million in Q4 2025.
Tg Therapeutics (TGTX) EBT (2011 - 2026) Analysis & Trends
Tg Therapeutics' EBT history runs 16 years deep, the most recent figure standing at $20.4 million for Q1 2026.
- In Q1 2026, EBT rose 272.4% year-over-year to $20.4 million; the TTM figure through Mar 2026 stood at $122.6 million (up 187.77% YoY), while the FY2025 annual figure was $107.7 million, up 307.02% from the prior year.
- EBT for Q1 2026 stood at $20.4 million, down from $45.4 million in the prior quarter.
- The five-year high for EBT was $113.9 million in Q3 2023, with the low at -$75.7 million in Q4 2022.
- The 5-year median for EBT is $4.3 million (2024), against an average of -$4.7 million.
- The sharpest annual moves came in 2024 and 2025: EBT tumbled 96.25% in 2024, then jumped 507.05% in 2025.
- Tg Therapeutics' EBT stood at -$75.7 million in 2022, then soared by 81.46% to -$14.0 million in 2023, then surged by 287.72% to $26.3 million in 2024, then jumped by 72.59% to $45.4 million in 2025, then plunged by 55.19% to $20.4 million in 2026.
- Business Quant data shows TGTX's EBT at $20.4 million in Q1 2026, $45.4 million in Q4 2025, and $25.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 10.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.23 Mn |
| Mar 31, 2026 | 20.36 Mn |
| Dec 31, 2025 | 45.44 Mn |
| Sep 30, 2025 | 25.91 Mn |
| Jun 30, 2025 | 30.92 Mn |
| Mar 31, 2025 | 5.47 Mn |
| Dec 31, 2024 | 26.33 Mn |
| Sep 30, 2024 | 4.27 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | -10.68 Mn |
| Dec 31, 2023 | -14.03 Mn |
| Sep 30, 2023 | 113.93 Mn |
| Jun 30, 2023 | -47.61 Mn |
| Mar 31, 2023 | -39.23 Mn |
| Dec 31, 2022 | -75.66 Mn |
| Sep 30, 2022 | -40.96 Mn |
| Jun 30, 2022 | -56.23 Mn |
| Mar 31, 2022 | -75.13 Mn |
| Dec 31, 2021 | -95.89 Mn |
| Sep 30, 2021 | -103.17 Mn |